Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K011709
    Date Cleared
    2001-11-08

    (157 days)

    Product Code
    Regulation Number
    866.3740
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    UNI-GOLD STREP A TEST KIT

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Trinity Biotech Uni-Gold™ Strep A test kit is intended for the rapid, in vitro qualitative detection of group A Streptococcal antigen from human throat swabs. It can also be used as a confirmation test of beta-haemolytic colonies obtained from blood agar plates. The test is intended for professional use in physicians offices as an aid in the rapid diagnosis of group A Streptococcal pharyngitis. The test may also be used in hospital laboratories as an aid in the rapid diagnosis of group A Streptococcal pharyngitis and the confirmation of group A Streptococcus from culture.

    Device Description

    The extracted sample flows through an absorbent pad containing anti-Strep A antibody conjugated to colloidal gold which binds group A Streptoccal antigen if present, forming an antigen-antibody complex. As this complex travels along the membrane, it becomes immobilised at the test region, which is impregnated with a rabbit polyclonal anti-Strep A antibody, resulting in the formation of a pink/red line. A pink/red line will also appear in the control region of the test indicating proper functioning of the test. In the absence of group A Streptococcal antigen, a pink/red line will only appear in the control line.

    AI/ML Overview
    1. Acceptance Criteria and Reported Device Performance:
    MetricAcceptance Criteria (Implied)Reported Device Performance (Uni-Gold Strep A)
    Accuracy (vs. Routine Culture)Not explicitly stated, but expected to demonstrate "good agreement"Overall agreement: 97.0% (486/501)
    Sensitivity (vs. Routine Culture)Not explicitly stated, but expected to be high.Sensitivity: 89.0% (97/109)
    Specificity (vs. Routine Culture)Not explicitly stated, but expected to be high.Specificity: 99.2% (389/392)
    Concordance (vs. Predicate Device)Expected to demonstrate "Good agreement."Positive Concordance: 96.6% (86/89)
    Negative Concordance: 96.6% (398/412)
    Overall Concordance: 96.6% (484/501)
    Culture Confirmation Sensitivity (vs. Streptococcal latex grouping test)Not explicitly stated, but expected to be high.Sensitivity: 96.3% (105/109) initially, then 98.1% (105/107) after resolving mixed cultures.
    Culture Confirmation Specificity (Identified non-Strep A)Expected to correctly identify non-Strep A colonies.100% (117/117) of negative samples were correctly identified in a separate study.
    Analytical SensitivityNot explicitly stated, but to determine the lowest detection level.1 x 10^5 cells per swab
    Analytical SpecificityExpected to show no cross-reactivity with common throat organisms.No interference by other organisms (pathological and nonpathological) routinely found in the throat.
    Relative Sensitivity (vs. Predicate with discordant results resolved against culture)Expected to be high.99.0% (97/98 positive results)
    Relative Specificity (vs. Predicate with discordant results resolved against culture)Expected to be high.99.3% (400/403 negative results)
    Relative Overall Agreement (vs. Predicate with discordant results resolved against culture)Expected to be high.99.2% (497/501)
    1. Sample Size for Test Set and Data Provenance:

      • Accuracy Study (Test Set 1): 501 fresh throat samples. Data provenance is not explicitly stated regarding country of origin, but it is a retrospective or concurrent collection as it was tested "both in the immunoassay and by routine culture."
      • Comparison to Predicate Device (Test Set 2): 501 total specimens tested. Data provenance is not explicitly stated.
      • Culture Confirmation Study (Test Set 3):
        • Initial: 109 samples visually positive for Strep A on blood agar plates.
        • Second part (non-Strep A confirmation): 224 samples, of which 117 were identified as non-Strep A.
        • Third part (blinded and duplicate testing): 6 samples (2 Group A beta-haemolytic, 4 non-Group A beta-haemolytic).
      • All these studies appear to be "test sets" as they are used to evaluate the device's performance directly.
    2. Number of Experts and Qualifications for Ground Truth of Test Set:

      • For the core clinical accuracy and comparison studies, the "routine culture" is considered the ground truth. There is no specific mention of "experts" adjudicating these results, as routine culture itself serves as the reference standard in these diagnostic tests.
      • For the Culture Confirmation Study (third part), "2 independent physicians" conducted blinded, duplicate testing. Their qualifications are not further specified beyond "physicians."
    3. Adjudication Method for Test Set:

      • In the primary clinical accuracy study, the Uni-Gold™ Strep A results were compared directly against "routine culture." There isn't an explicit adjudication method described beyond this direct comparison.
      • For the comparison between Uni-Gold™ Strep A and the predicate device, discordant results were later "resolved against culture" when calculating relative sensitivity/specificity/agreement. This implies that if the two devices disagreed, a third reference (culture) was used to determine the true positive/negative status for performance calculation. This is a form of an adjudication process, likely a 2+1 type (two devices, one gold standard for resolution).
    4. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

      • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly done. The device is an immunoassay, not an imaging device that would typically involve human readers interpreting results with or without AI assistance. The studies performed compare the device's performance against a reference standard (culture) and a predicate device.
    5. Standalone (Algorithm Only) Performance:

      • Yes, the performance values presented (sensitivity, specificity, agreement, concordance) are for the Uni-Gold™ Strep A test kit operating as a standalone device, without human-in-the-loop assistance in its core detection mechanism. The human interaction is usually limited to performing the test and reading the results, which is inherent to the use of such a diagnostic kit.
    6. Type of Ground Truth Used:

      • Primary Ground Truth: Routine culture (specifically for Group A Streptococcus). This is a well-established laboratory method for identifying bacterial presence and is considered a high-quality reference standard for infectious disease diagnostics.
      • Secondary Ground Truth (for Culture Confirmation): Initial culture results confirmed by "Beta-haemolysis and morphology" and "Streptococcal latex grouping test" for further confirmation.
    7. Sample Size for Training Set:

      • The document does not provide information about a separate "training set" for the Uni-Gold™ Strep A test kit. As an immunoassay (lateral flow assay), it is a biochemical test, not a machine learning algorithm that typically requires a distinct training phase with a dedicated dataset. The device's components and assays are developed and validated during the manufacturing process, rather than "trained" on data.
    8. How Ground Truth for Training Set Was Established:

      • Not applicable, as there is no explicit "training set" in the context of this immunoassay device. The scientific principles and reagents are developed based on known biological interactions and established laboratory methods. Analytical studies (sensitivity, specificity) ensure the components function as intended.
    Ask a Question

    Ask a specific question about this device

    K Number
    K982373
    Date Cleared
    1999-02-11

    (219 days)

    Product Code
    Regulation Number
    866.3740
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    UNI-GOLD STREP A TEST KIT

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Trinity Biotech Uni-Gold™ Strep A Test Kit is a rapid immunoassay for the qualitative detection of Streptococcal A antigen from throat swabs, or the confirmation of beta-hemolytic colonies obtained from blood agar plates.

    The Trinity Biotech Uni-Gold™ Strep A Test Kit is intended for use in hospital laboratories and physicians' offices as an aid in the diagnosis of Group A Streptococcal pharyngitis.

    Device Description

    Immunoassay: Strep A antigen, when present, binds to the anti-Strep A antibody conjugated to a gold dye. As this complex travels along the membrane, it becomes immobilized at the test region, resulting in the formation of a red line. Excess antibodygold conjugate further migrates along the membrane and binds to the control region, forming another red line. In the absence of Strep A antigen, a red line will only be formed at the control region.

    AI/ML Overview

    Here's an analysis of the provided text to extract the acceptance criteria and study information:

    Acceptance Criteria and Device Performance Study for Uni-Gold™ Strep A Test Kit

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly state "acceptance criteria" in a numerical or percentage format. Instead, it describes analytical performance parameters that the device demonstrated. The primary "acceptance" for this 510(k) submission is substantial equivalence to the predicate device, which implies comparable performance in key areas.

    ParameterAcceptance Criteria (Implied by Predicate Equivalence)Reported Device Performance (Uni-Gold™ Strep A Test Kit)
    Analytical SensitivityComparable to predicate device's sensitivity1.0 x 10^5 cells/swab
    Analytical SpecificityNo cross-reactivity with common interfering organismsNo false positives with tested organisms at 1 x 10^6 concentration (Staphylococcus aureus at 1 x 10^6 organisms)

    2. Sample Size Used for the Test Set and Data Provenance

    The document focuses on analytical studies rather than clinical studies with patient samples for the test set.

    • Analytical Sensitivity Test Set: Serial dilutions of S. pyogenes cultures. The exact number of dilutions or individual tests performed is not specified, only that testing continued until interpretations became "negative."
    • Analytical Specificity Test Set: The sample size for the analytical specificity (cross-reactivity) test set includes 19 different organisms. For each organism, testing was performed at a concentration of approximately 1 x 10^6 (or 1 x 10^6 for Staphylococcus aureus).
    • Data Provenance: The studies are described as "Laboratory studies" and did not involve human subjects. Thus, data provenance in terms of country of origin or retrospective/prospective is not applicable in the typical clinical sense. These are in-house, non-clinical evaluations.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This section is not applicable. The studies described are analytical (laboratory-based) and do not involve human interpretation of results for establishing ground truth. The "ground truth" for analytical sensitivity was known concentrations of S. pyogenes, and for analytical specificity, the known identity and concentration of non-Strep A organisms.

    4. Adjudication Method for the Test Set

    This section is not applicable as the studies are analytical and do not involve human adjudication of results in the way clinical studies often do. The results (positive/negative) would be determined by the visual presence or absence of a red line.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The document describes laboratory analytical performance, not a study evaluating human reader performance with or without AI assistance.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    Yes, the studies described are standalone in the sense that they evaluate the performance of the device itself (the immunoassay) without human-in-the-loop performance being a variable. The test results (red line present/absent) are interpreted directly from the device's output.

    7. Type of Ground Truth Used

    • Analytical Sensitivity: Known concentrations of Streptococcus pyogenes (Strep A) cultures.
    • Analytical Specificity: Known identities and concentrations of various non-Strep A organisms.

    8. Sample Size for the Training Set

    This information is not applicable. The Uni-Gold™ Strep A Test Kit is an immunoassay (a rapid diagnostic test), not an AI/Machine Learning algorithm. Therefore, there is no "training set" in the context of AI development.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable as there is no training set for an AI algorithm.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1